GIROLAMO TODD C (CLO, SVP of Corp Dev) received a stock award from LISATA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/12/2022ACC: 0001891257-22-000002
Officer· CLO, SVP of Corp Dev
Since Jun 2021
+171.87K
Net shares
Net buyer
$20.0K
Total sold
0
Open market trades
0B · 0S
4
Total transactions
194K acquired · 22.13K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+129K
Price / share
—
Trade value
—
% of position
219.9%
1/10/2022
58.67K→187.68K
Common Stock
Direct
Shares
−17.41K
Price / share
$0.92
Trade value
$15.96K
% of position
9.3%
1/10/2022
187.68K→170.27K
Common Stock
Direct
Shares
−4.72K
Price / share
$0.87
Trade value
$4.09K
% of position
2.8%
1/11/2022
170.27K→165.55K
Total
Net shares
+106.87K
Net value
-$20.05K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/10/2022 | A · Award | +129K | — | — | 219.9% | 58.67K | 187.68K |
| Common Stock Direct | 1/10/2022 | F · Tax Withholding | −17.41K | $0.92 | $15.96K | 9.3% | 187.68K | 170.27K |
| Common Stock Direct | 1/11/2022 | F · Tax Withholding | −4.72K | $0.87 | $4.09K | 2.8% | 170.27K | 165.55K |
| Total | +106.87K | -$20.05K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
65K shares
Shares
+65K
Strike price
0.917
Held after
65K
Exercisable
—
1/10/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock65K shares | 1/10/2022 | A · Award | +65K | 0.917 | — | 65K |